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1 These authors contributed equally to this work.Bone Morphogenetic Proteins (BMPs) are critical for pattern formation in many animals. In numer-
ous tissues, BMPs become distributed in spatially non-uniform proﬁles. The gradients of signaling
activity can be detected by a number of biological assays involving ﬂuorescence microscopy. Quan-
titative analyses of BMP gradients are powerful tools to investigate the regulation of BMP signaling
pathways during development. These approaches rely heavily on images as spatial representations
of BMP activity levels, using them to infer signaling distributions that inform on regulatory mech-
anisms. In this perspective, we discuss current imaging assays and normalization methods used to
quantify BMP activity proﬁles with a focus on the Drosophila wing primordium. We ﬁnd that nor-
malization tends to lower the number of samples required to establish statistical signiﬁcance
between proﬁles in controls and experiments, but the increased resolvability comes with a cost.
Each normalization strategy makes implicit assumptions about the biology that impacts our inter-
pretation of the data. We examine the tradeoffs for normalizing versus not normalizing, and discuss
their impacts on experimental design and the interpretation of resultant data.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Bone Morphogenetic Proteins (BMPs) regulate development and
homeostasis of numerous tissues in both vertebrates and inverte-
brates (Wu & Hill, 2009). The model organism Drosophila melano-
gaster is an outstanding system to investigate novel mechanisms
for BMP regulation, due to the sophisticated tools available to test
for BMP signaling in whole tissues. BMPs regulate many events
throughout the Drosophila life cycle, including embryonic axial pat-
terning (reviewed in [1,2]), growth and patterning of appendage
primordia (reviewed in [3,4]), and maintenance of germline stem
cells (reviewed in [5,6]), to name a few. However, current debate
about the biological robustness of BMP-mediated patterning in
Drosophila tissues is fueled, in part, by differences in data interpre-
tation, which can arise from different approaches to quantitative
comparisons of developmental patterns between control and test
samples [7–14].chemical Societies. Published by E
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mulis).
aftery), dumulis@purdue.eduRecently, developmental analyses have been applied to deter-
mine the biophysics of transport [12,15], the cell biological re-
sponse to extracellular BMPs (e.g. [16]), and to build
mathematical models of tissue morphogenesis [7,8,10,12–18].
Such computational studies rely upon the quantiﬁcation of micro-
scopic images obtained as assay results (for a general perspective
on bioimage informatics, see [19]). Both intrinsic biological vari-
ability and extrinsic experimental variability are present in these
images, creating challenges that need to be overcome in order to
draw conclusions with adequate statistical power. However, few
investigators have addressed basic questions about how the quan-
tiﬁcation should be done. Here we offer our perspective on quanti-
tative assays for spatial distributions of BMP activity, using the
speciﬁc case of Drosophila wing development, and suggest how
the results apply to other developmental contexts.
In all systems studied, the spatial and temporal distribution of
BMP activity is tightly controlled for proper development and
homeostasis. Regulatory interactions occur at all levels of BMP sig-
naling, including ligand activity and availability, ligand–receptor
binding, and the lifetime of activated signal transducers [2]. For
example, multiple extracellular proteins (e.g. Crossveinless-2, Short
Gastrulation/Chordin, Noggin, and Collagen), bind competitively to
secreted BMP ligands and restrict both ligand diffusion and local
binding to signaling receptors. By their very nature, these regulatorylsevier B.V. All rights reserved.
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ity across a tissue. The dynamic complexity of this tissue-wide net-
work has led to computational tests of molecular mechanisms.
Althoughwe are in early stages of this exciting approach, such stud-
ies open the door to understanding BMP signaling in the systems le-
vel context of tissue function integrated in space and time.
Computational tests of mechanistic models rely on quantitative
data collected from biological experiments. To interrogate the
dynamics of BMP signaling across whole tissues, immunoﬂuores-
cent staining and microscopic imaging are the principal tools. Both
input (extracellular BMP ligands) and output (phospho-RSmad or
target gene expression) can be quantiﬁed using established biolog-
ical assays, e.g. immunostaining or transgenic, ﬂuorescent proteins
[8,12,15,9,20,21]. Increasing numbers of studies of tissue pattern-
ing by BMPs and other morphogens use numerical representations
of images for a quantitative comparison between control and
experimental populations [8–10,12,22–28]. However, individual
laboratories follow their own methods for extracting quantitative
data from microscopic images, often without explicitly describing
them in resultant publications. Manipulation of quantitative data
has similarly proceeded by ad hoc approaches.
It is widely recognized that a biological assay transforms the
true biological information in the tissue, such as the total number
or concentration of a molecular species, into a quantitatively dis-
tinct observation such as ﬂuorescence intensity patterns in a
microscopic image. In a typical study, control and experimentally
manipulated animals are reared in parallel, tissue specimens are
isolated and processed in parallel, and digital images are obtained
using a sophisticated ﬂuorescence detection system, such as a la-
ser-scanning confocal microscope (LSCM) [9,10,12,21]. For each
population multiple specimens are imaged, and these image data
sets are compared. To augment such comparisons, population sta-
tistics are used to test for signiﬁcant differences between control
and experimental populations [29].
Recently, some investigators have critically evaluated whether
common image quantiﬁcation methods are appropriate for the
analysis of image data from experimental manipulations of mor-
phogens acting in Drosophila embryonic patterning [10,23,30–32].
In Section 2, we use these evaluations as a starting point to focus
speciﬁcally on the challenges that emerge when examining BMP
activity distributions. The selection of assay carries with it different
sources of biological and assay variability that critically impact deci-
sions about the design and interpretation of experimental results.
In particular, the observed data has added variability from
material, observational and conceptual error [33]. These errors im-
pact experiment-to-experiment variability, sample-to-sample var-
iability, and specimen variability, in which an experiment is
composed of aggregated samples from manipulated and control
populations, and each sample population is composed of multiple
specimens. The cumulative variability impacts our ability to dis-
criminate any real differences between the experimental and con-
trol specimen populations. These mixed sources of variability lead
to measurement error that hinders analysis of biological pattern
formation by BMPs.
Increasing sample population size through normalization of
data sets might improve an investigator’s ability to quantify spatial
patterns. However, normalization can alter the data in unexpected
ways and potentially bias interpretation of the biology. In Section 3,
we take a theoretical view of the kinds of variation that are present
in the data, and the post-processing approaches that are taken to
minimize variation within and between populations of data. Here-
in we aim to offer our perspective by focusing on the following
questions: (1) How many specimens are needed for satisfactory
discriminatory power between control and experimental popula-
tions? (2) Should data be normalized, and if so, which type of im-
age normalization provides the most faithful representation of thebiological information? (3) What properties of a morphogen gradi-
ent should be measured and used in comparison tests? This discus-
sion provides a starting point for future consideration of methods
to quantitate morphogen gradients and evaluate BMP signaling
during development.2. Tradeoffs in assay design: examples from Drosophila wing
primordia
While tradeoffs exist in any quantitative imaging experiment,
we focus on patterning of the Drosophila wing primordium. Flies
are holometabolous insects, inwhichmassive growth occurs during
the larval stages, and then adult structures develop their ﬁnal form
during a non-feeding pupal stage [34]. Adult appendage develop-
ment begins in discrete cell populations that form structures called
imaginal disks [35]. Imaginal disks grow extensively during larval
stages, with spatial patterning events that restrict regions of the tis-
sue to speciﬁc adult fates. Eachwing develops from a speciﬁc region
of a wing imaginal disk, the wing primordium (Fig. 1). By unknown
mechanisms, imaginal disk growth is coordinated throughout the
organism, so that each appendage is appropriately sized for the
overall size of the individual ﬂy. Furthermore, patterning and
growth are coordinated, so that all aspects of adult structure are
proportional, or scaled to size [36]. Recent computational studies
of BMP signaling in wing development have focused on how the
distribution of BMP activity scales with tissue size [7,9].
Proteins of the Drosophila BMP signaling network are highly
conserved with mammalian BMP signaling proteins, but are gener-
ally named via an idiosyncratic genetic nomenclature. The BMP2/4
ligand ortholog is Decapentaplegic (Dpp); for wing primordia, the
BMP 5/6/7/8 class ligand is Glass Bottom Boat (Gbb) (recently re-
viewed in [37–39]). Just as in mammalian BMP signaling, ligand
binding recruits a heteromeric complex of a type II receptor, which
is a constitutive serine–threonine kinase, with a type I receptor
that is a conditional serine–threonine kinase [40]. The transient
ligand-type I–type II complex permits type II receptor-mediated
activation of the type I receptor, which then phosphorylates a
BMP R-Smad. Phosphorylated R-Smad accumulates in the nucleus,
oligomerizes with the co-Smad, and interacts with other transcrip-
tion factors to directly regulate expression of numerous genes. The
Drosophila BMP R-Smad ortholog is Mothers Against Dpp (Mad).
Antibodies that detect the phosphorylated form of Mad (pMad),
are commonly used to assay the levels and spatial distribution of
BMP activity in ﬂy tissues, although some analyses use transgenic
proteins tagged with ﬂuorescent proteins.
2.1. Impact of assay variability on quantitative image data
To frame the discussion on tradeoffs between approaches, it is
helpful to consider the types of variability that leads to error in a
typical biological assay. There are two primary types of error in
an assay: random error of measurement and systematic error of
measurement. Allchin et al. further categorize experimentally-
introduced errors according to their origins: material error, obser-
vational error, and conceptual error [33].
Material error originates from physical conditions that cannot
be perfectly controlled. The alterations might be multiplicative
and/or additive to the true biological data, scaling the molecular
concentration data. Multiplicative error poses a signiﬁcant prob-
lem since each subsequent step in the process of imaging and
quantiﬁcation has the potential to multiply earlier errors, leading
to compounding errors akin to compounding interest for a bank
account.
Observational error originates from human involvement in the
process of research and refers to inadvertent errors based on the
Fig. 1. Natural size variation in wing imaginal discs. Row (A) and row (B) show ﬂuorescence images of two wing discs isolated from the same cohort of larvae (genotype: y w;
Ap-Gal4, UAS-GFP/+; brk-lacZ/+) and processed in the same trial. (A and B), merged images. (A0 and B0): GFP reporter (blue in merged images) for dorsal cells. (A00 and B00) Delta
(red in merged images), indicating the pattern used to stage tissues (mouse a-delta, DHSB, #C594.9B; Cy5-goat a mouse, Jackson Laboratories, #115–175-003). (A000 and B000)
PhosphoMad (green in merged images, rabbit a -phospho-Smad1/5, Ser463/465, Cell Signaling, #9516, Alexa 568-goat a-rabbit, Invitrogen, #A11011). Raw images from each
channel acquired sequentially with a Nikon A1R LSCM at 20 magniﬁcation (0.75 NA) 512  512 pixel resolution, and 8-bit pixel depth. Merges and maximum intensity
projections produced with Nikon elements software. Image adjustments were made simultaneously to all panels with Photoshop.
1944 A. Brooks et al. / FEBS Letters 586 (2012) 1942–1952observer interaction with data acquisition. For example, the
speciﬁc parameter settings used for image acquisition (image
metadata, [41]) can alter the signal-to-noise ratio, resulting in
observational error in the raw images obtained.
Conceptual error arises predominately through steps that are ta-
ken post-acquisition and depends on the soundness of theoretical
formulation for data manipulations. An example is whether images
are scaled prior to data analysis (see Section 2.3.1). Further concep-
tual error can result from choices of statistical methods, precision
of computational routines and choice of normalization strategy.
2.2. Selection of signaling assays
The selection of assay has signiﬁcant impact on the type and le-
vel of experimental error, which ultimately impacts the type of
questions that can be addressed by the data and the level of statis-
tical trustworthiness of the data. For example, live imaging of a
Dpp-ﬂuorescent protein fusion eliminates many steps needed for
a typical antibody staining, but the introduction of the fusion pro-
tein into an organism could alter the state of the system leading to
results that do not reﬂect the endogenous situation.
In general, ﬂuorescence microscope imaging is the method of
choice for quantitative image analysis, but it has numerous pitfalls,
which are extensively reviewed elsewhere [42–44]. We focus on
the experimental design that provides a ﬂuorescent marker for
BMP activity.
2.2.1. Direct detection of ﬂuorescent BMP protein distribution
Fluorescent protein (FP)-tagged proteins are attractive reagents
to detect BMP distribution in living samples [15]. Direct FP ﬂuores-
cence provides ameasure of the number of molecules present at the
location of each pixel [45,46]. However, a FP tag has signiﬁcant po-
tential to interfere with protein function because of its size; for
example, a GFP tag is a 238 amino acid moiety. Additional deviation
from native biological morphogen distributions may arise from the
methods used to express the tagged protein within the tissue. For
example GFP::Dpp transgenes are expressed in wing primordiausing a binary, transgenic expression system (Gal4-UAS, [47]) that
has apparently spatially appropriate expression conferred by a por-
tion of the dpp cis-regulatory region; but with this system, the fu-
sion protein does not fully rescue dpp mutant phenotypes. Thus, a
transgenic construct may provide an inaccurate assay via a system
that is related to, but not equivalent to, the endogenous situation,
even thoughmaterial error is reduced because the immunostaining
reactions are removed from the assay.
2.2.2. Indirect detection of BMP activity
Because additional regulation occurs at the levels of ligand
accessibility to receptor, ligand–receptor complex lifetime, and
receptor binding to R-Smad, assays of intracellular responses are
often used to evaluate the distribution of BMP signal activity. The
most widely used assay is immunodetection of pMad (Fig. 1, exam-
ple proﬁles extracted in Fig. 2). Several antibody reagents are avail-
able, and all give qualitatively similar results [48–50]. However,
this assay is not universally appropriate, because it is an indirect
detection assay that only works on ﬁxed tissues.
Expression of BMP target genes, or transgenic reporters derived
from them, is another common assay. Transgenic reporters
expressing FPs, such as dad-RFP [12], can be used to follow the
dynamics of BMP activity distribution in living specimens [12].
However, transcriptional responses are the integrated output from
interactions of multiple transcription factors (e.g. regulation of vg
by BMP and Wg pathways [54]). Thus, reporter or target gene
expression may not be faithful to the distribution of BMP activity.
2.3. Assay contributions to data variability
2.3.1. Size variation
A widespread challenge to whole tissue imaging is size variabil-
ity within a population of organisms (examples in Fig. 1). Cur-
rently, investigators choose between three approaches to manage
size variation. The ﬁrst is to perform quantitative comparisons
without consideration of the overall size of each specimen [51].
A second approach is to modify culture methods to strictly limit
Fig. 2. BMP activity proﬁles. (A), (B) PhosphoMad staining in wing primordium regions from specimens in Fig. 1. Yellow stripes indicates where the proﬁles in (A0), (B0) were
quantiﬁed. (A0), (B0) Phospho-Mad intensity proﬁles from a ventral position15% offset from the dorsal/ventral boundary. Images acquired at 40 magniﬁcation (NA 1.3), and
images processed as for Fig. 1. Each value in the proﬁle is the mean of a 1  8 pixel window. The images were annotated in Fiji. The proﬁles were generated using the statistics
software R.
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advantage of not perturbing the image data, but limits the num-
bers of specimens that can be collected for each sample.
The third approach to size variability is to convert all image data
to the same scale, either during image processing or while process-
ing the extracted quantitative data. Data from wing primordia may
be scaled using a length metric that is moderately independent of
BMP activity (length parallel to the anterior–posterior boundary).
This treatment systematically transforms the data from each spec-
imen, but has not been assessed for ﬁdelity of the processed data to
the original data. For this reason, scaling image data during initial
processing may not be appropriate.
2.3.2. Day to day variability in assay parameters
Variability in assay parameters is a fundamental feature of
experimental science. Often cell biologists measure assay variabil-
ity with replicate assays on the same biological material [29]. For
imaging experiments, each assay repeat requires new specimens,
so that replication is not possible. Because a new sample of speci-
mens is obtained each time an imaging assay is repeated, we will
use ‘‘trial’’ to refer to each parallel treatment of samples.
A common approach to manage assay variability is to restrict
comparisons to control and experimental specimen populations
that were assayed in the same trial. For tissues acquired by micro-
dissection, this approach places a strong constraint on either the
number of specimens for each test population (e.g. [9]), or the num-
ber of populations directly compared (e.g. [21]). Additional control
specimens may be included to measure background levels from
non-speciﬁc staining [8,12]. Alternatively, background levels may
be minimized for each specimen with offset adjustments during
image acquisition [41], which confounds quantitative comparisons.
Data normalization to manage assay variability is increasingly
used for quantitative analyses of image data. This approach facili-
tates the accumulation of larger specimen populations from multi-ple assay trials, and thus provides a two-pronged approach to
limiting variability. Data can be normalized in the form of an im-
age, or as extracted quantitative representations. Different meth-
ods of normalization are available; in Section 3 we consider how
simulated biological data is transformed by normalization and
how this may affect interpretation of the data. Speciﬁcally, Sec-
tion 3 demonstrates how some normalization methods may alter
the population characteristics, such as the mean.
3. Quantifying BMP activity distributions
To detect differences between control and experimental popu-
lations or to constrain mathematical models, knowledge about
the contributions of the assay to ﬁnal variability can greatly inform
early decisions on how images should be processed. The types,
estimated amounts, and sources of variability all impact our exper-
imental design and also need to be considered in the selection of
image comparison and analysis metrics. We start by considering
local variability within an image.
3.1. Impact of local biological variability on quantitative image data
In addition to specimen-to-specimen variability within a sam-
ple, local variation occurs within a single specimen. Within each
cell, reaction rates ﬂuctuate over time as a result of dynamic vari-
ations in local molecular concentrations and variability in local
extrinsic factors such as the behaviors of neighboring cells. Such
molecular scale events affect ligand production rates, uptake rates,
transport rates, and other processes that occur at the cellular scale
[8]. Additional pixel-to-pixel variability is contributed by the ﬂuo-
rescent imaging modality used for image acquisition [52]. Thus,
both biological and assay variability may appear as ﬂuctuations
in the intensity proﬁle from a single specimen (Fig. 3), which other-
wise would be expected to appear smooth. These ﬂuctuations
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the same relative location. A widespread and simple approach to
manage such internal variability is to generate each point in the
intensity proﬁle by averaging the values for a group of adjacent
pixels (e.g. Fig. 2). This method reduces point-to-point variationFig. 3. Sources, mathematical descriptions and summary of error contributions to the m
as the wing primordium, is shown here to demonstrate how biological patterns have inhe
plots, the horizontal axis represents spatial position along the anterior/posterior tissue
intensity (assay). A total of 20 simulated samples is shown in the plot, where the blue
assumptions are applied in the system: molecule A is (1) present at the left-most region
decays with rate k.within an image, with the assumption that molecular levels are lo-
cally uniform.
Despite the inherent variation from cell to cell, each specimen
exhibits a proﬁle pattern that is stereotypical for a genetically re-
lated population. Important insights into the underlying moleculareasurement of BMP signaling. Top: An example protein distribution in a tissue, such
rent variability and how variability accumulates during experimental assays. For all
axis and the vertical axis is the concentration (biology) or measured ﬂuorescent
lines are individual simulated samples and red is the mean proﬁle. The following
of the sample in constant amount, (2) diffuses across the X axis at rate D, and (3)
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throughout an experimentally manipulated population. Thus, in
whole tissue studies, a common goal is to extract overall pattern
information from the inherently variable data. A specimen’s proﬁle
pattern can be smoothed using a mathematical spline function
[12,49], but it is unknown how this affects ﬁdelity to the original
data. We focus on the effects of data normalization on the proﬁle
pattern. In Section 3.2, we computationally simulated a molecular
concentration pattern, in order to compare the efﬁciency of speciﬁc
normalization approaches to processing quantitative image data.
3.2. Evaluation of quantitative image analysis methods
Whether the goal is to detect phenotypic differences or to esti-
mate the uncertainty for measured biophysical parameters, one
must consider howmany samples are needed to establish statistical
power for the conclusions. We use this concept of statistical power
to frame our analysis of normalization approaches, for the simple
reason that most biological experiments have limited sample size.
We analyze a simulated data set generated using a reaction–diffu-
sion model for Dpp movement across posterior cells of wing pri-
mordia (Fig. 3), based on earlier work by Bollenbach et al. [8].
3.2.1. Model data sets used for evaluation
To create the simulated dataset, the reaction–diffusion model
includes sources of biological variability that are time-invariant
to represent cell-to-cell differences in the primordium that confer
local variability in the biophysical parameters for production /, dif-
fusion D, and kinetic uptake/decay k (Fig. 3) [8]. The results of this
model calculation create a baseline ‘‘biological’’ concentration pro-
ﬁle that we refer to as the Ground Truth (GT) data. Multiplicative
and additive errors are added to the ‘‘specimen’’ as a whole and
pointwise, to approximate error introduced by each step of the as-
say, the image acquisition, and the processing steps used to extract
quantitative intensity proﬁles. The output of this second model,
simulating the addition of assay material and observational error,
produces a population of morphogen distributions that each repre-
sents the ‘‘observed’’ (OB) data equivalent to a proﬁle from an
LSCM image of specimen ﬂuorescence.
This approach gives us two simulated data sets: (1) the GT data
that contains only biological variability, and (2) the OB data that
contains both biological and experimental variability. These data
are useful as a test case, but we recognize that our data simulation
includes assumptions that contribute to conceptual error, and that
machine error (truncation error in computer decimals) leads to
minor material error in the numerical solutions to the model. Esti-
mation of minimum population size and evaluation of normaliza-
tion methods are entwined and need to be evaluated together
since the estimate for minimum population size depends on the
normalization strategy.
3.2.2. Overview of three methods for data normalization
Whether or not image data should be normalized is controver-
sial, and rightly so. This data processing step is potentially danger-
ous, depending on how the process transforms the original data.
While each normalization method generates proﬁles that superﬁ-
cially resemble the GT data (Fig. 4A–E), each method makes differ-
ent implicit assumptions about the underlying biology that directly
impact the resultant interpretation.
A common normalization method, which we call the ‘‘anchor
point’’ (AP) method, is to set the maximum intensity value (from
a single pixel or a local average of pixel intensities) from each spec-
imen equal to the same maximum value, often using arbitrary
units. This method imposes the implicit assumption that each indi-
vidual in the sampled population can exquisitely control the level
of morphogen or signal at a spatial location (method AP1). Theassumption is not generally valid. A related strategy, used to inves-
tigate Bcd patterning, is to force the maxima and minima (or the
average of subpopulations of data points) to be equal to one and
zero respectively, implying two biological assumptions about the
data (method AP2) [26,31,32]. Lastly, an extension of the AP meth-
od is to set subpopulations of the image data to an average of the
top 5% and bottom 5% of the pixels and this is equivalent to a max
and min ﬁlter (AP3). AP3 type normalization may also occur during
image acquisition from the scaling and gain algorithms in LSCM
controller software.
The ‘‘integral’’ (IN) normalization method divides each proﬁle
by the value of the background-subtracted morphogen proﬁle’s
integral over the domain of measurement [8]. The resulting proﬁles
all have equal integrals, which imposes the implicit assumption on
the normalized data that each specimen contains the same number
of the molecular species assayed. This assumption has not been
tested in a biological context, and is not consistent with our cur-
rent understanding of stochastic, physical variability between cells,
as discussed in Section 3.1.
‘‘Model-based’’ (MB) normalization imposes the implicit
assumption that specimen to specimen variation is primarily due
to assay-dependent errors in measurement for each observation,
e.g. variations in overall ﬂuorescent intensity for an immuno-
stained sample. This approach assumes that the true biological
data is transformed into the observed data, by a mathematical
function for the biological assay. The parameters for the function
will vary signiﬁcantly from trial to trial and to a lesser extent be-
tween specimens within a trial, and may contain both multiplica-
tive and additive errors. The overall goal of this normalization
strategy is to minimize the error between the observed intensity
data and the expected result from the ‘‘model’’ prediction. For a lin-
ear model, this produces a new data set that minimizes the
squared error between individual specimens and the mean for
the population of specimens and has been referred to as a variance
minimization approach or a v2 minimizer. MB normalization that
used a linear model was ﬁrst used to investigate the reliability of
Bicoid (Bcd)-mediated embryonic patterning and subsequently to
investigate dorsal surface patterning by BMPs [10,22,31].
MB normalization requires an estimate ‘‘model’’ or ‘‘function’’
for the assay parameters that transform the biological data into ob-
served data. Then, computational methods seek the optimal
parameters for the function that minimizes the difference between
each observation and the model estimate for the observation. To
establish the approach, Gregor et al. showed that immunostaining
for Bcd and live-imaging of embryos with a Bcd–-GFP fusion pro-
tein produce ﬂuorescent intensity distributions that are linear
functions of concentration [22]. A linear relationship between ﬂuo-
rescent intensity and concentration gives the function
In = An⁄cn + Bn, where In is the intensity, cn is the concentration for
each image n, and An and Bn are the scaling parameters that trans-
form the concentration data into the measured ﬂuorescent inten-
sity. Each An and Bn can be different for each image within a
population due to intrinsic and extrinsic variability.
If one assumes that the majority of image-to-image systematic
variability is experimentally introduced, then the observations In
can be explained by variability in the parameters for the assay
(An, Bn) that transform the true biological mean cmean(x) into each
observed ﬂuorescent intensity proﬁle. Following the minimization
routine (Fig. 4), the result of the normalization is the selection of
each An and Bn, an estimate for each cn(x) consistent with the meth-
od, and cmean(x), the mean concentration for the data set. The vari-
ability in the intensity is absorbed by the model parameters that
scale the true mean biological data (an unknown, but calculated
quantity) to the model predicted intensity. While the method is
theoretically based on inverting the function that transforms true
biological data (unknown) into the observable quantity, it is
Fig. 4. Comparison of normalization methods. Left column: summary of approach. (A–E) Normalization of GT data by AP1, AP2, IN, and MB approaches. (F–J) Same as (A–E)
except applied to OB data.
1948 A. Brooks et al. / FEBS Letters 586 (2012) 1942–1952incapable of distinguishing between sources of variability. To sum-
marize, the implicit assumption in model-based normalization is
that the ‘‘true’’ biological data is robust and highly reproducible be-
tween individuals within a population, and that the majority of the
observed variability is caused by the assay. Since the method can-
not distinguish between sources of individual-to-individual multi-
plicative variability, it also imposes this assumption on the data
being normalized and can lead to normalized data with lower esti-
mates for the variability than is present in the specimen population.
3.2.3. Evaluation of normalization strategies
The major goals for normalization are to reduce the variability
introduced by the observer, improve conﬁdence in measuredquantities, and reach more reliable conclusions about the biology.
We used our model data sets (See Section 3.2.1) to determine
whether normalization achieves these goals, or instead hinders
our ability to measure biological parameters and detect differences
between populations. The model data give us the advantage of
starting with an initial data set that we know with certainty. We
refer to this initial data as GT data. The data with variability added
to each point yields the OB data. Normalized data sets are gener-
ated by each strategy: OB (not normalized), AP1, AP2, AP3, IN,
and MB, and each normalized data set is compared against GT data
to estimate the impact for that strategy. Since normalization estab-
lishes proﬁles on a relative (normalized) scale with ‘‘arbitrary units
(au)’’, the mean of each population is adjusted so that they all have
Fig. 5. Normalization impact on mean and standard deviation of sample data. (A) Comparison of mean proﬁles after normalization. (B) Error in mean. (C) Estimation of
standard deviation after normalization for 5% assay noise. (D) same as (C), except with 10% noise.
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the GT data.
To acquire good estimates for the population mean and stan-
dard deviation for each data set, the model was simulated 5000
times. While this is an unrealistic number in any morphogen imag-
ing experiment, simulating large numbers is necessary so we can
later estimate minimum populations sizes needed to achieve sta-
tistical signiﬁcance in a typical experiment.
3.2.4. Normalization’s potential pitfalls and successes
Normalization allows for larger populations sizes by aggregat-
ing data from different trials that may provide greater statistical
power to measure variables within and between samples. A pri-
mary concern for normalization is that the process can systemati-
cally alter the data, and in some cases our interpretation of the
biology. To investigate normalization’s positive and negative im-
pacts, we measured how each normalization method discussed
above changes the population-level statistics for GT and OB data.
GT data still contains simulated biological variability that will im-
pact the output of each method in different ways and this test
serves as a ‘‘worst case’’ scenario for normalization’s impact on
interpretation. OB data provides a more realistic trial with data
that contains both biological and experimental variability. In
Fig. 4A–E, it is clear how each normalization method impacts the
GT data and leads to quantitatively different distributions of mor-
phogen patterns. AP1 and AP2 pinch the distributions at the max
(AP1) or both max and min (AP2) with higher variability in theproﬁles between the anchor points. Both MB and IN methods re-
duce the variability in the GT data and demonstrate how normali-
zation can impact data and our subsequent interpretation of data
in the hypothetical case when there is NO experimental variability
(the perfect assay). When 5% normally distributed noise (see Fig. 3)
is applied pointwise across each individual for imaging, detector
noise, stochastic reaction events in the assay, etc. and 20%multipli-
cative and additive trial-to-trial variability is applied to yield OB
data, the normalization methods differentiate relative to each
other in the resultant distributions. AP1 and AP2 lead to greater
amounts of variability far from the anchor points, whereas MB
and IN ‘‘appear’’ closer to the GT data.
We observed qualitatively similar mean morphogen proﬁles be-
fore and after normalization, except for AP3, (not shown in Fig. 4)
which overestimates the concentration distribution relative to
other methods (see Fig. 5A). To conﬁrm this observation, we plot-
ted the difference between the mean after normalization and the
mean of the GT data (Fig. 5B). There was no measurable difference
between the mean for the GT data and any of the means from the
OB, AP1, AP2, IN, and MB data, even with large population sizes
that exceed what is feasible in a typical experiment. The applica-
tion of multiplicative and additive error to the ground truth data
did not lead to a different mean (Fig. 5A,B), and this is expected
since we applied normally distributed error, consistent with our
expectation for each step of the assay.
We then calculated the error in the standarddeviation (r) in con-
centration for eachdata set andplotted the error inr as a functionof
Fig. 6. Sample size estimation. (A–C) Estimated sample sizes for measuring a (A) difference in concentration (data from each population are labeled 10%, 20%, 40%, and 60%,
the percent decrease in the mean decay rate k), (B) position shift at a threshold, and (C) changes in decay length k. (D) Estimates for sample sizes to detect concentration
differences as a function of the assay variability.
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points tested and showed the greatest difference when compared
against the ground truth data. AP1 and AP2 normalization led to
varying results in the estimate ofr that depends strongly on relative
location. Consistent with the previous evaluation of the method for
Bcd data [26,31], anchoring by max and min leads to overestimates
ofrbetween the anchorpoints. In effect, variability that exists in the
maxandminareeliminatedat thecostof transmitting thevariability
to intermediate spatial positions. Gregor et al. thoroughly described
how this can impact the interpretation of the underlying biology of
Bcd patterning [31]. Normalization by the IN and MB methods lead
tobetter approximations forr, but thereare tradeoffs.With5%assay
noise, IN leads to an overestimate of ther relative to GT throughout
the distribution, whereas MB underestimates r near the peak con-
centration and overestimates it throughout the remainder of the
proﬁle. With 10% noise, all methods lead to standard deviations
greater than GT data, and the MB approach overestimates by the
smallest amount relative to the other methods.
3.2.5. Normalization’s impact on detecting differences between
morphogen proﬁles
The ability to detect differences between test versus control
populations is central to experimental design, and normalizationcan have a large impact on our ability to draw conclusions from
the acquired data. In particular, it is essential for studies of mor-
phogen patterning robustness and reproducibility. Unfortunately
this ﬁeld is peppered with different approaches to assessing the ex-
tent of similarity between the extracted patterns from control and
test populations. Normalization impacts our ability to detect differ-
ences between extracted patterns, so we extended the method to
estimate the minimum numbers of samples needed in each popu-
lation to have a power of 0.9 and a = 0.05 as a function of the
strength of the biological perturbation and the three proﬁle param-
eters used: intensity, shift in spatial position at a threshold, or
lambda, the decay length.
We simulated the biophysical morphogen model using vari-
able values of the decay/endocytosis constant that alters the
range of morphogen movement (on average). The values are
similar to recent experimental results that suggest Pentagone
impacts the range of BMP activity in the wing primordia [53].
We simulated the data from experimental populations where
the decay rate is reduced from wild-type levels. The estimate
for the number of samples needed to detect a difference between
control and experiment are shown for each normalization method
and GT data in Fig. 6 A. Small differences in the decay rate require
relatively large populations to reject the null hypothesis for all
A. Brooks et al. / FEBS Letters 586 (2012) 1942–1952 1951methods, with the greatest sample size needed for the unnormal-
ized OB.
The selection of proﬁle metrics also inﬂuenced the sample size
needed. If either a shift in position or lambda was used for compar-
ison between control and experiment, the minimum population
size was lower than when detecting differences in concentration
(Fig. 6B,C). The minimum requirement for lambda varied from pop-
ulation sizes of 3 to >30 depending on the extent of the perturba-
tion. Measures in the spatial shift of the gradient at a threshold
level required intermediate population sizes. Unexpectedly, fewer
samples were needed to detect a difference after normalization
by the MB method than were needed for the GT data. This suggests
that normalization can go too far and eliminate some natural bio-
logical variability.
Lastly, we examined how the results for sample size changes as
a function of the assay error caused by noise. Additionally, since
normalization can impact the distributions of GT data, there is a
point where normalization should not be used. To test this, we esti-
mated sample sizes to detect a difference in concentration for as-
say noise (pointwise variability) that increased from 1% up to
15%. For all runs, the trial-to-trial variability was ﬁxed at 20%.
For assays with very low noise, normalization reduces r, leading
to estimates that are lower than the minimum required for GT
data. At 5% noise and above, normalization reduces the required
sample sizes relative to OB data.
In summary, these simulations show that normalization is use-
ful to reduce the sample size needed in order to detect differences
between control and experimental populations of sample images.
If the ability to obtain samples is a limiting factor in experimental
design, AP1, and AP2 are the least desirable methods, as they re-
quire the most samples to detect the same level of difference be-
tween control and test samples in an experiment. The most
desirable method, in our opinion, is the MB approach that provided
consistent estimates for mean and standard deviation throughout
the exponential gradient that were close to the GT data. Two pro-
ﬁle metrics, k and positional shift at a threshold concentration, re-
quire fewer samples to detect differences in patterns than
measuring differences in concentration.
4. Summary and perspective
The primary goal for this evaluation is to initiate an open dialog
on the quantiﬁcation of BMP signaling during development. With
the growing recognition of the intricate networks for BMP signal-
ing, there will be even greater reliance on quantitative imaging
technologies and analysis methods to interpret the underlying
biology and elucidate the regulatory networks. We emphasize that
assay design for image quantiﬁcation should be considered at the
outset. Our evaluation using a simulated data set suggests that
some normalization methods are more appropriate than others,
and that experimental design should include consideration of
how the normalization might affect the resultant data and experi-
mental interpretation.
Each normalization method relies on assumptions that impact
interpretation, but caution is advised when considering the AP
methods. AP1 and AP2 signiﬁcantly distort the standard deviation
of the data relative to GT data and AP3 alters the mean of the dis-
tribution relative to GT, as demonstrated by Gregor et al. [31].
There are many approaches that we did not consider here. In
particular, similar evaluation is needed for approaches such as
the evaluation of internal controls to compare data between multi-
ple different experiments (or labs) and the comparison of non-
exponential type gradients. In summary, when quantitative image
data are used to infer mechanisms of morphogen patterning, the
reported methods should include details about each image pro-
cessing step, how the data were normalized, and a rationale forthe choice of method. The increased attention to trade-offs in data
normalization will improve our quantitative understanding of
morphogen-mediated patterning and the cell biology of BMP
signaling.
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